Current Approaches to the Management of Diabetic Retinopathy and Diabetic Macular Oedema

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.16, 2010-11, pp. : 2171-2200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ranibizumab: In Diabetic Macular Oedema

By Frampton James E.

Drugs, Vol. 72, Iss. 4, 2012-03 ,pp. : 509-523

Adis International

Access to resources Recommend Favorite

Pioglitazone: Diabetic macular oedema: case report

Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. : 38-38

Adis International

Access to resources Recommend Favorite

Rosiglitazone: Diabetic macular oedema: case report

Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. : 45-45

Adis International

Access to resources Recommend Favorite

Current and future pharmacological intervention for diabetic retinopathy

By Comer Grant M Ciulla Thomas A

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 441-455

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF Molecules for the Management of Diabetic Macular Edema

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4731-4737

Bentham Science Publishers

Access to resources Recommend Favorite